Trial Details

Recruiting
Basic Information
Clinical ID c2023
Identifier KCT0009951
Trial Title A multicenter, prospective, open-label study to evaluate the efficacy and safety of subcutaneous infliximab in patients with inflammatory bowel disease treated with various doses of intravenous infliximab.(FLOW study)
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions ;Diseases of the digestive system
Interventions -
Participant Information
Sponsor The Catholic University of Korea, St. Vincent's Hospital
City -
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type Observational Study
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -